Population: Adults (18-64 years)

M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

Crandell

Portugal Brazil
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • Monkeypox virus
  • Blood sample
  • PBMC
  • Pharmacological intervention
  • Vaccination
  • MVA-BN
  • Dryvax

Packer

United Kingdom
|
2022-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Community
  • Monkeypox virus

Martínez-Arias

Spain
|
2022-2023
  • Adults (18-64 years)
  • General population
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Primary care
  • Monkeypox virus

Drennan

United Kingdom
|
2022-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • STD/STI clinic
  • Monkeypox virus
  • Pharmacological intervention
  • Vaccination

Caldrer

Italy
|
2022-2022
  • Adults (18-64 years)
  • General population
  • People at high risk of STIs
  • Men who have sex with men
  • Hospital
  • Infectious diseases unit
  • Monkeypox virus
  • Blood sample
  • Serum sample

STIMULATE-ICP

United Kingdom of Great Britain and Northern Ireland
|
2022
  • Adults (18-64 years)
  • General population
  • Community
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Colchicine
  • Antihistamines
  • Rivaroxaban

RECLAIM

The Netherlands
|
2025
  • Adults (18-64 years)
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post COVID-19 condition
  • Post-acute infection syndrome
  • Pharmacological intervention
  • Immunomodulator
  • Colchicine
  • Metformin

COVID COHORT – SPAIN

Spain
|
2020-2025
  • Adults (18-64 years)
  • General population
  • Hospital
  • SARS-CoV-2
  • Blood sample
  • PBMC
  • Whole blood

ZIKAllianceCH

Bolivia (Plurinational State of) Brazil Colombia Guadeloupe Mexico Venezuela (Bolivarian Republic of)
|
2018-2022
  • Adults (18-64 years)
  • General population
  • Infants (<1 year)
  • Children (1-11 years)
  • Pregnant women
  • Community
  • Arbovirus
  • Vector-borne disease
  • Zika virus
  • Blood sample
  • Urine sample
  • Hair
  • Saliva
  • Semen
  • Vaginal fluids

VaQDENV

Italy
|
2024-2028
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Outpatient clinic
  • Arbovirus
  • Dengue virus
  • Vector-borne disease
  • Blood sample
  • Pharmacological intervention
  • Vaccination
  • Qdenga